Biophytis
Research Biophytis (0D1W) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker0D1W
- ExchangeLSE
- CountryFrance
- CurrencyEUR
About Biophytis
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company's lead drug candidate is the BIO101 to treat obesity, respiratory infections due to Covid-19, sarcopenia, and Duchenne Muscular Dystrophy (DMD). It has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD.
Frequently asked questions
What does Biophytis do?
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases.